Market Place
Sourcing Support
OliX Pharma Receives HREC Approval to Initiate Phase 1 Clinical Trial of NASH
22 Dec 2023 //
BUSINESSWIRE
OliX Administers First Patient in Phase 1 Clinical Study of OLX72021
13 Jun 2023 //
BUSINESSWIRE
OliX Presents Data Showing Weight Loss from anti-NASH siRNA and Semaglutide
11 May 2023 //
BUSINESSWIRE
OliX Inks MOU with DynamiCure Biotechnology to Develop ADC Immunotherapy
10 May 2023 //
BUSINESSWIRE
OliX Announces Results from a Phase 2a Trial of OLX10010 for Hypertrophic Scar
28 Apr 2023 //
BUSINESSWIRE
OliX Doses First Patient in Clinical Trial for RNAi Therapeutic OLX10212
27 Mar 2023 //
BUSINESSWIRE
OliX Receives Approval to Commence PI Trial of Treatment of Androgenic Alopecia
23 Mar 2023 //
BUSINESSWIRE
OliX Pharma Publishes Preclinical Research Demonstrating OLX104C’s Potential
22 Nov 2022 //
BUSINESSWIRE
OliX Announces Positive Preclinical Data in NASH Non-human Primate Models
07 Nov 2022 //
BUSINESSWIRE
OliX Pharma Submits IND to FDA to Evaluate OLX10212 in PI Trial
01 Jul 2022 //
BUSINESSWIRE
mCureX Announces mRNA Technology Collaboration with ToolGen
15 Jun 2022 //
BUSINESSWIRE
OliX Pharma to Conduct Business Meetings with Potential Partners at 2022 BIO
09 Jun 2022 //
BUSINESSWIRE
OliX Pharma Completes Enrollment in PII Trial of OLX101A in Hypertrophic Scars
03 Jun 2022 //
BUSINESSWIRE
OliX Completes $45M Capital Raise for R&D and Financials
25 May 2022 //
BUSINESSWIRE
OliX Pharma Identifies Effective Inhibition of Target Gene Expression
04 May 2022 //
BUSINESSWIRE
OliX Pharma Inhibits Target Gene Expression in Nonhuman Primate Models
08 Apr 2022 //
PRNEWSWIRE
OliX Pharmaceuticals to Participate in BIO-Europe Spring
23 Mar 2022 //
BUSINESSWIRE
OliX Pharma Presents Potential Utility of GalNAc-asiRNA Platform at OPT Congress
16 Mar 2022 //
BUSINESSWIRE
OliX Pharmaceuticals to Present at SMi 13th Annual RNA Therapeutics Conference
07 Feb 2022 //
GLOBENEWSWIRE
Hansoh, J&J, Brii and more—Fierce Pharma Asia
22 Oct 2021 //
FIERCEPHARMA
OliX Pharma Enters Agreement with Pharmaron to Advance Non-clinical Toxicology
20 Oct 2021 //
GLOBENEWSWIRE
Chinese powerhouse continues charge into siRNA with Silence pact
15 Oct 2021 //
FIERCEBIOTECH
Inhibrx shares rise on PhI trial results; Braglia`s Helsinn partners with Fosun
12 Oct 2021 //
ENDPTS
Hansoh Pharma and OliX Pharmaceuticals Enter into Licensing and Collaboration
12 Oct 2021 //
GLOBENEWSWIRE
OliX to Present at 2021 Oligonucleotide Therapeutics Society Virtual Conference
24 Sep 2021 //
GLOBENEWSWIRE
OliX Pharmaceuticals Signs Agreement with LGC Biosearch Technologies
09 Jun 2021 //
GLOBENEWSWIRE
OliX and PCI Biotech announce a collaboration to combine OliX asiRNA
05 May 2021 //
GLOBENEWSWIRE
OliX Announces Results from Preclinical Study of Hair Loss Therapeutic Candidate
10 Feb 2021 //
GLOBENEWSWIRE
OliX Announces Completion of $37.2 M Capital Raise U.S. Expansion
01 Dec 2020 //
GLOBENEWSWIRE
OliX Announces FDA Clearance of the IND to Evaluate the Efficacy of OLX10010
30 Oct 2020 //
BIOSPACE
OliX Pharmaceuticals Announces Expansion of Collaboration with Laboratoires Théa
07 Oct 2020 //
GLOBENEWSWIRE
OliX to Present New Data in Liver and Ophthalmic Areas at 16th Meeting (OTS)
29 Sep 2020 //
GLOBENEWSWIRE
OliX Pharmaceutical Announces IND Submission of OLX10010 to USFDA
27 Sep 2020 //
BIOSPACE
OliX Pharmaceuticals Signs Agreement with LGC Biosearch Technologies
16 Jun 2020 //
GLOBENEWSWIRE
